Zdrowie i gospodarka · 21/07/2026
FDA Extends Comment Period for Expedited IND Pilot Program Proposal
The FDA is extending the comment period for a proposal to establish a pilot program that aims to shorten the time it takes to bring new drugs to market while protecting clinical trial participants, in response to a request for information from the public.